But let's talk about what's going on with the ResMed CDI (ASX: RMD) share price. Whilst the ASX 200 is having a bad day, it's been far worse for Resmed shares. This ASX 200 healthcare stock closed ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Bank of America Securities analyst Lyanne Harrison reiterated a Buy rating on Resmed (RMD – Research Report) today and set a price target of $270.00. Lyanne Harrison’s rating is based on the ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

Upgrade your Yahoo Finance plan to get complete details for ResMed Inc. Get advanced tools and insights to navigate the markets.

ResMed RMD, a leading provider of cloud-connected medical devices, has unveiled new patient-centric products designed to enhance the therapy journey for sleep apnea patients. These include the ...

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD ... the stock to “Underperform,” setting a price target of $180. Polark is concerned that Eli Lilly and ...

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, ...